Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T20:33:35.694Z.
Calculation as of: 2026-10-06T20:33:35.694Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 967c3c4e1026402272b5761d24a9cd8122a999a0fe4ad26a1d84866f163ab752
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
0.38x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$58.44M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.02M
EV/Sales Ratio
N/A
TTM Avg
236.83x
3Y Avg
178.58x
5Y Avg
259.06x
Market Cap
$60.42M
EV/Sales Ratio
N/A
TTM Avg
10156.67x
3Y Avg
5697.35x
5Y Avg
5697.35x
Market Cap
$57.61M
EV/Sales Ratio
56866.56x
TTM Avg
24657.57x
3Y Avg
9404.59x
5Y Avg
5624.70x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | $59.18M | N/A | 0.38x | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | N/A | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | N/A | 8.16x | 93.50x | 96.95x |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | 236.83x | 178.58x | 259.06x |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | N/A | 10156.67x | 5697.35x | 5697.35x |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A | N/A | N/A | N/A |
| Talphera, Inc. (TLPH)vs › | $57.61M | 56866.56x | 24657.57x | 9404.59x | 5624.70x |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 0.73x |
| 2026-10-02 | 0.70x |
| 2026-10-01 | 0.67x |
| 2026-09-30 | 0.72x |
| 2026-09-29 | 0.68x |
| 2026-09-28 | 0.72x |
| 2026-09-25 | 0.71x |
| 2026-09-24 | 0.70x |
| 2026-09-23 | 0.68x |
| 2026-09-22 | 0.71x |
| 2026-09-21 | 0.71x |
| 2026-09-18 | 0.74x |
| 2026-09-17 | 0.71x |
| 2026-09-16 | 0.69x |
| 2026-09-15 | 0.71x |
| 2026-09-14 | 0.68x |
| 2026-09-11 | 0.68x |
| 2026-09-10 | 0.68x |
| 2026-09-09 | 0.69x |
| 2026-09-08 | 0.67x |
| 2026-09-04 | 0.70x |
| 2026-09-03 | 0.71x |
| 2026-09-02 | 0.65x |
| 2026-09-01 | 0.66x |
| 2026-08-31 | 0.69x |
| 2026-08-28 | 0.70x |
| 2026-08-27 | 0.70x |
| 2026-08-26 | 0.72x |
| 2026-08-25 | 0.72x |
| 2026-08-24 | 0.76x |
| 2026-08-21 | 0.77x |
| 2026-08-20 | 0.77x |
| 2026-08-19 | 0.82x |
| 2026-08-18 | 0.85x |
| 2026-08-17 | 0.85x |
| 2026-08-14 | 0.75x |
| 2026-08-13 | 0.70x |
| 2026-08-12 | 0.08x |
| 2026-08-11 | 0.12x |
| 2026-08-10 | 0.13x |
| 2026-08-07 | 0.12x |
| 2026-08-06 | 0.15x |
| 2026-08-05 | 0.10x |
| 2026-08-04 | 0.09x |
| 2026-08-03 | 0.08x |
| 2026-07-31 | 0.10x |
| 2026-07-30 | 0.09x |
| 2026-07-29 | 0.09x |
| 2026-07-28 | 0.11x |
| 2026-07-27 | 0.09x |
| 2026-07-17 | 0.03x |
| 2026-07-16 | 0.07x |
| 2026-07-15 | 0.10x |
| 2026-07-14 | 0.07x |
| 2026-07-13 | 0.14x |
| 2026-07-10 | 0.09x |
| 2026-07-09 | 0.13x |
| 2026-07-08 | 0.15x |
| 2026-07-07 | 0.16x |
| 2026-07-06 | 0.20x |
| 2026-07-02 | 0.11x |
| 2026-07-01 | 0.13x |
| 2026-06-30 | 0.24x |
| 2026-06-29 | 0.15x |
| 2026-06-26 | 0.08x |
| 2026-06-25 | 0.03x |
| 2026-06-24 | 0.07x |
| 2026-06-23 | 0.03x |
| 2026-06-22 | 0.05x |
| 2026-05-14 | 0.01x |
| 2026-01-09 | 0.05x |
| 2026-01-08 | 0.24x |
| 2026-01-07 | 0.16x |
| 2026-01-06 | 0.11x |
| 2026-01-05 | 0.03x |
| 2026-01-02 | 0.01x |
| 2025-12-12 | 0.05x |
| 2025-12-11 | 0.18x |
| 2025-12-10 | 0.22x |
| 2025-12-09 | 0.28x |
| 2025-12-08 | 0.27x |
| 2025-12-05 | 0.27x |
| 2025-12-04 | 0.32x |
| 2025-12-03 | 0.16x |
| 2025-12-02 | 0.17x |
| 2025-12-01 | 0.32x |
| 2025-11-28 | 0.40x |
| 2025-11-26 | 0.36x |
| 2025-11-25 | 0.39x |
| 2025-11-24 | 0.37x |
| 2025-11-21 | 0.38x |
| 2025-11-20 | 0.36x |
| 2025-11-19 | 0.62x |
| 2025-11-18 | 0.36x |
| 2025-11-17 | 0.25x |
| 2025-11-14 | 0.17x |
| 2025-05-13 | 0.51x |
| 2025-05-05 | 0.11x |
| 2025-05-02 | 0.21x |
| 2025-05-01 | 0.27x |
| 2025-04-30 | 0.37x |
| 2025-04-29 | 0.27x |
| 2025-04-28 | 0.57x |
| 2025-04-25 | 1.02x |
| 2025-04-24 | 1.11x |
| 2025-04-23 | 0.66x |
| 2025-04-22 | 0.83x |
| 2025-04-21 | 0.88x |
| 2025-04-17 | 0.23x |
| 2025-04-16 | 0.29x |
| 2025-04-02 | 0.03x |
| 2025-03-28 | 0.17x |
| 2025-03-27 | 0.01x |
| 2025-03-26 | 0.04x |
| 2025-03-25 | 0.32x |
| 2025-03-24 | 0.58x |
| 2025-03-21 | 0.62x |
| 2025-03-20 | 0.56x |
| 2025-03-19 | 0.66x |
| 2025-03-18 | 0.47x |
| 2025-03-17 | 0.80x |
| 2025-03-14 | 0.72x |
| 2025-03-13 | 0.72x |
| 2025-03-12 | 0.98x |
| 2025-03-10 | 0.17x |
| 2025-03-07 | 1.04x |
| 2025-03-06 | 1.38x |
| 2025-03-05 | 1.05x |
| 2025-03-04 | 0.35x |
| 2025-03-03 | 0.99x |
| 2025-02-28 | 1.00x |
| 2025-02-27 | 0.82x |
| 2025-02-26 | 1.99x |
| 2025-02-25 | 0.80x |
| 2025-02-24 | 1.46x |
| 2025-02-21 | 1.34x |
| 2025-02-20 | 3.12x |
| 2025-02-19 | 4.63x |
| 2025-02-18 | 3.81x |
| 2025-02-14 | 4.22x |
| 2025-02-13 | 6.28x |
| 2025-02-12 | 8.89x |
| 2025-01-22 | 0.79x |
| 2025-01-21 | 6.01x |
| 2025-01-17 | 4.22x |
| 2025-01-16 | 4.22x |
| 2025-01-15 | 3.40x |
| 2025-01-14 | 3.40x |
| 2025-01-13 | 3.67x |
| 2025-01-10 | 3.67x |
| 2025-01-08 | 3.95x |
| 2025-01-07 | 2.30x |
| 2025-01-06 | 2.44x |
| 2025-01-03 | 3.67x |
| 2025-01-02 | 3.26x |
| 2024-12-31 | 1.68x |
| 2024-12-30 | 1.89x |
| 2024-12-27 | 1.92x |
| 2024-12-26 | 1.95x |
| 2024-12-24 | 4.36x |
| 2024-12-23 | 3.81x |
| 2024-12-20 | 6.14x |
| 2024-12-19 | 1.44x |
| 2024-12-18 | 0.46x |
| 2024-12-17 | 1.30x |
| 2024-12-16 | 1.72x |
| 2024-12-13 | 1.87x |
| 2024-12-12 | 2.71x |
| 2024-12-11 | 2.85x |
| 2024-12-10 | 3.26x |
| 2024-12-09 | 3.40x |
| 2024-12-06 | 3.53x |
| 2024-12-05 | 2.99x |
| 2024-12-04 | 2.99x |
| 2024-12-03 | 2.57x |
| 2024-12-02 | 2.85x |
| 2024-11-29 | 3.53x |
| 2024-11-27 | 2.44x |
| 2024-11-26 | 2.19x |
| 2024-11-25 | 0.67x |
| 2024-11-22 | 0.82x |
| 2024-11-21 | 1.20x |
| 2024-11-20 | 1.49x |
| 2024-11-19 | 2.57x |
| 2024-11-18 | 1.92x |
| 2024-11-15 | 2.85x |
| 2024-11-14 | 1.71x |
| 2024-11-13 | 2.27x |
| 2024-11-12 | 3.40x |
| 2024-11-11 | 3.53x |
| 2024-11-08 | 2.16x |
